Predictors of fatality in influenza A virus subtype infections among inpatients in the 2015–2016 season

•The case fatality rate of Influenza A(H3N2) was significantly higher than influenza A(H1N1).•Detection of the infection, allowing opportunity for the early use of antiviral agents, was found to be important for prevention of fatality.•The vaccination should be should be prioritized for at-risk grou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of infectious diseases 2019-04, Vol.81, p.6-9
Hauptverfasser: Tekin, S., Keske, S., Alan, S., Batirel, A., Karakoc, C., Tasdelen-Fisgin, N., Simsek-Yavuz, S., Isler, B., Aydin, M., Kapmaz, M., Yilmaz-Karadag, F., Ergonul, O.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•The case fatality rate of Influenza A(H3N2) was significantly higher than influenza A(H1N1).•Detection of the infection, allowing opportunity for the early use of antiviral agents, was found to be important for prevention of fatality.•The vaccination should be should be prioritized for at-risk groups. Infection with the influenza A virus can cause severe disease and mortality. The effect of the different subtypes of influenza on morbidity and mortality is not yet known in Turkey. The aim of this study was to describe the predictors of fatality related to influenza A infection among hospitalized patients in Istanbul during the 2015–2016 influenza season, and to detail the differences between infections caused by H3N2 and H1N1. This was a multicenter study performed by the Istanbul Respiratory Infections Study Group of The Turkish Society of Clinical Microbiology and Infectious Diseases (KLİMİK), among patients hospitalized for influenza in Istanbul during the 2015–2016 influenza season. A total of 222 patients hospitalized with laboratory-confirmed influenza during the 2015–2016 season were included in the study, of whom 25 (11.2%) died. The fatality rate was significantly higher among patients older than 65 years of age and those with chronic heart and kidney diseases (p
ISSN:1201-9712
1878-3511
DOI:10.1016/j.ijid.2019.01.005